Search

everythinglearnresearchcommunity

for

Search:↓

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

CS12192 effectively treats alopecia areata with better safety than current options.

The F9 formulation of Finasteride tablets, using Eudragit, successfully controlled drug release.

Bicalutamide, a drug with a good safety profile, is a promising new treatment for female pattern hair loss.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Alpinia zerumbet is a promising medicinal herb with various health benefits.

Croton membranaceus root extract can change how drugs are processed in the body.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

AZD6244 treatment causes skin aging effects by depleting skin stem cells.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Adding zinc to pyrithione zinc improves its effectiveness against scalp conditions like dandruff.

Zinc sulfide cellulose scaffolds can reduce scarring and promote hair growth.

A new treatment using unactivated platelet leukocyte autoplasma cured 80% of non-scarring alopecia patients.

Baricitinib helps treat severe hair loss in people over 65.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

The new delivery method for dutasteride is more effective and has fewer side effects.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

SH-340 may improve skin barrier and help treat atopic dermatitis.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Overdosing on veterinary albendazole can cause severe health issues like hair loss and low blood cell count.

The hydrogel helps heal diabetic wounds quickly and effectively.